Skip to content

Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments

A Pilot Study to Explore the Effects of Lower-Leg Mechanical Tactile Sensory Stimulation on the Gait Speed of Mildly Cognitively Impaired Individuals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05723822
Enrollment
12
Registered
2023-02-13
Start date
2023-02-16
Completion date
2023-03-31
Last updated
2023-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Decline, Gait Disorders in Old Age, Mild Cognitive Impairment

Brief summary

The primary aim of this pilot study is to investigate the effect of Walkasins, a wearable lower-limb sensory prosthesis, on the gait speed and balance function of participants with mild cognitive impairment as measured by the Saint Louis University Mental Status (SLUMS) Examination.

Detailed description

The Walkasins system is one of a growing number of wearable devices that use various modalities of neuromodulation, defined as the alteration of nerve activity through targeted delivery of a stimulus . . . to specific neurological sites in the body (https://www.neuromodulation.com/). Because these technologies are relatively new, innovative applications of their use in various patient populations may lead to improvements in the care and quality of life of individuals who suffer from these life-altering diagnoses. Previous studies of Walkasins have shown that individuals with peripheral neuropathy who have gait and balance problems walk faster with the Walkasins device. This increase may be related to an improved automaticity of gait function, which decreases the need for cognitive attention to the walking task, which is known to slow down gait. Individuals with mild cognitive impairment commonly show slow gait speeds, likely due to a decline in executive function. There is a reason to think that sensory stimuli from the Walkasins device can improve the automaticity of gait in these individuals and thereby enhance gait speed.

Interventions

DEVICEWalkasins

Walkasins is a non-invasive, wearable, lower limb sensory prosthesis, prescribed by a healthcare professional for long-term daily use as a prosthesis. It directly replaces the part of the function of the sensory end organs that persons with peripheral neuropathy have lost, the sensation in the soles of their feet. The system is comprised of two primary operating components: * A Receptor Sole, properly placed in the shoe, detects and transmits plantar pressure information normally performed by the mechanoreceptors and distal axons in the soles of the feet. * A Haptic Module, worn around the lower leg, generates directional specific mechanical tactile stimuli that produce action potentials that signal relevant balance information to the nervous system.

Sponsors

Innovative Design Labs
CollaboratorINDUSTRY
RxFunction Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ambulatory person who is at least 65 years of age * Ability to understand and provide informed consent * Ability to perceive vibrations from the Walkasins Haptic Module * Ability to complete the functional outcome measures without the use of an assistive device * Foot size that allows the Walkasins to function appropriately * Mild Cognitive Impairment (MCI) as measured by the Saint Louis University Mental Status (SLUMS) Exam (scores between 20 and 24 + or -2 for those with less than a high school education and scores between 21-26 + or -2 for those who graduated from high school, which indicate mild cognitive impairment) and/or a diagnosis of MCI (or related term) in the person's medical record * Slow gait speed (\<1m/second or slightly faster, provided all other criteria are met)

Exclusion criteria

* Use of ankle-foot orthosis for ambulation that prevents donning of Walkasins * Self-reported acute thrombophlebitis including deep vein thrombosis * Untreated lymphedema * Untreated lesion of any kind, swelling, infection, inflamed area of skin or eruptions on the lower leg near product use * Untreated fractures in the foot and ankle * Self-reported severe peripheral vascular disease * Other neurological conditions that impact walking (e.g., peripheral neuropathy) * Weighs more than 300 pounds

Design outcomes

Primary

MeasureTime frameDescription
Change in 4-Meter Gait Speed (Section 2 of the Short Physical Performance Battery)3 Times During 1 Session <1.5 Hours (Screening + Walkasins Off Condition then Walkasins On Condition)The 4-meter gait speed test measures the number of seconds it takes a person to walk four meters on a level surface. Gait speed measures are a significant indicator of a person's functional mobility. Higher gait speeds (meters/second) are better than lower gait speeds and are indicative of better functional mobility. (Generally, gait speeds less than 1m/second are considered slow.)

Secondary

MeasureTime frameDescription
Short Physical Performance Battery (SPPB)Twice During 1 Session <1.5 Hours (Walkasins Off Condition then Walkasins On Condition)The Short Physical Performance Battery measures walking speed, standing balance, and sit-to-stand performance. Scores on balance, gait speed, and chair-stand tests are added (summed) for a total score. (Scores on balance, gait speed, and chair-stand tests are not reported separately since they are not subscales per se.) SPPB scores may range from 0 to 12. Higher total scores indicate better balance and gait.
Timed Up and Go (TUG)Twice During 1 Session <1.5 Hours (Walkasins Off Condition then Walkasins On Condition)The Timed Up and Go Test is part of the Centers for Disease Control (CDC)-recommended STEADI test protocol for balance function. From a seated position in a standard armchair, the participant is asked to stand up from the chair, walk to a line on the floor 10 feet away at normal pace, turn, walk back to the chair at normal pace, and sit down again. The tester records the time taken from the command Go until the subject sits down again. Lower times indicate better/faster performance.
Timed Up and Go Cognitive (TUG-COG)Twice During 1 Session <1.5 Hours (Walkasins Off Condition then Walkasins On Condition)The TUG-COG is performed similarly to the TUG; however, the participant is also asked to count backwards by 3 from a randomly selected number between 20 and 100 while performing the TUG (standing up from the chair, walking to a line on the floor 10 feet away, turning, walking back to the chair at a normal pace, and sitting down again). Lower times indicate better/faster performance.
Falls Efficacy ScaleOnce During 1 Session <1.5 HoursThe Falls Efficacy Scale is a 16-item questionnaire that measures an individual's fear of falling or concerns about falling during activities of daily living. Scores may range from 16 (not at all concerned) to 64 (very concerned). Lower scores are better than higher scores because they indicate less concern about falling.

Countries

United States

Participant flow

Participants by arm

ArmCount
Walkasins and PhySens-IMM System--Single Arm
Participants who meet the eligibility criteria will don a pair of Walkasins and the PhySens-IMM System. They will perform some brief balance exercises (i.e., sensory integration exercises) and then complete the outcome assessments first with their Walkasins turned off and without the use of an assistive device. After a rest period of about five minutes, they will repeat the outcome assessments with their Walkasins turned on.
12
Total12

Baseline characteristics

CharacteristicWalkasins and PhySens-IMM System--Single Arm
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
12 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous84.8 Years
STANDARD_DEVIATION 7.4
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
11 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
11 Participants
Region of Enrollment
United States
12 participants
Saint Louis University Mental Status (SLUMS) Test23.5 Score on a Scale
STANDARD_DEVIATION 2.6
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 12
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Change in 4-Meter Gait Speed (Section 2 of the Short Physical Performance Battery)

The 4-meter gait speed test measures the number of seconds it takes a person to walk four meters on a level surface. Gait speed measures are a significant indicator of a person's functional mobility. Higher gait speeds (meters/second) are better than lower gait speeds and are indicative of better functional mobility. (Generally, gait speeds less than 1m/second are considered slow.)

Time frame: 3 Times During 1 Session <1.5 Hours (Screening + Walkasins Off Condition then Walkasins On Condition)

ArmMeasureGroupValue (MEAN)Dispersion
Walkasins and PhySens-IMM System--Single ArmChange in 4-Meter Gait Speed (Section 2 of the Short Physical Performance Battery)Baseline Assessment for Eligibility0.79 Meters/SecondStandard Deviation 0.16
Walkasins and PhySens-IMM System--Single ArmChange in 4-Meter Gait Speed (Section 2 of the Short Physical Performance Battery)Walkasins OFF0.82 Meters/SecondStandard Deviation 0.18
Walkasins and PhySens-IMM System--Single ArmChange in 4-Meter Gait Speed (Section 2 of the Short Physical Performance Battery)Walkasins ON0.79 Meters/SecondStandard Deviation 0.2
Secondary

Falls Efficacy Scale

The Falls Efficacy Scale is a 16-item questionnaire that measures an individual's fear of falling or concerns about falling during activities of daily living. Scores may range from 16 (not at all concerned) to 64 (very concerned). Lower scores are better than higher scores because they indicate less concern about falling.

Time frame: Once During 1 Session <1.5 Hours

ArmMeasureValue (MEAN)Dispersion
Walkasins and PhySens-IMM System--Single ArmFalls Efficacy Scale32.2 Score on a ScaleStandard Deviation 7.6
Secondary

Short Physical Performance Battery (SPPB)

The Short Physical Performance Battery measures walking speed, standing balance, and sit-to-stand performance. Scores on balance, gait speed, and chair-stand tests are added (summed) for a total score. (Scores on balance, gait speed, and chair-stand tests are not reported separately since they are not subscales per se.) SPPB scores may range from 0 to 12. Higher total scores indicate better balance and gait.

Time frame: Twice During 1 Session <1.5 Hours (Walkasins Off Condition then Walkasins On Condition)

ArmMeasureGroupValue (MEAN)Dispersion
Walkasins and PhySens-IMM System--Single ArmShort Physical Performance Battery (SPPB)Walkasins OFF8.2 Score on a ScaleStandard Deviation 1.9
Walkasins and PhySens-IMM System--Single ArmShort Physical Performance Battery (SPPB).Walkasins ON7.5 Score on a ScaleStandard Deviation 2.1
Secondary

Timed Up and Go Cognitive (TUG-COG)

The TUG-COG is performed similarly to the TUG; however, the participant is also asked to count backwards by 3 from a randomly selected number between 20 and 100 while performing the TUG (standing up from the chair, walking to a line on the floor 10 feet away, turning, walking back to the chair at a normal pace, and sitting down again). Lower times indicate better/faster performance.

Time frame: Twice During 1 Session <1.5 Hours (Walkasins Off Condition then Walkasins On Condition)

ArmMeasureGroupValue (MEAN)Dispersion
Walkasins and PhySens-IMM System--Single ArmTimed Up and Go Cognitive (TUG-COG)Walkasins OFF21.64 SecondsStandard Deviation 7.1
Walkasins and PhySens-IMM System--Single ArmTimed Up and Go Cognitive (TUG-COG)Walkasins ON18.85 SecondsStandard Deviation 6.96
Secondary

Timed Up and Go (TUG)

The Timed Up and Go Test is part of the Centers for Disease Control (CDC)-recommended STEADI test protocol for balance function. From a seated position in a standard armchair, the participant is asked to stand up from the chair, walk to a line on the floor 10 feet away at normal pace, turn, walk back to the chair at normal pace, and sit down again. The tester records the time taken from the command Go until the subject sits down again. Lower times indicate better/faster performance.

Time frame: Twice During 1 Session <1.5 Hours (Walkasins Off Condition then Walkasins On Condition)

ArmMeasureGroupValue (MEAN)Dispersion
Walkasins and PhySens-IMM System--Single ArmTimed Up and Go (TUG)Walkasins OFF15.46 SecondsStandard Deviation 5.4
Walkasins and PhySens-IMM System--Single ArmTimed Up and Go (TUG)Walkasins ON15.83 SecondsStandard Deviation 5.66

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026